These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19470037)

  • 1. Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial.
    Russo AM; Day JD; Stolen K; Mullin CM; Doraiswamy V; Lerew DL; Olshansky B
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):973-8. PubMed ID: 19470037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between women and men with ICDs: myth or reality?
    Pelargonio G; Bisceglia C
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):979-81. PubMed ID: 19563354
    [No Abstract]   [Full Text] [Related]  

  • 5. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
    Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of right ventricular pacing in patients with dual-chamber ICDs.
    Olshansky B; Day J; McGuire M; Hahn S; Brown S; Lerew DR
    Pacing Clin Electrophysiol; 2006 Mar; 29(3):237-43. PubMed ID: 16606390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial.
    Russo AM; Stamato NJ; Lehmann MH; Hafley GE; Lee KL; Pieper K; Buxton AE;
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):993-8. PubMed ID: 15363069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs (INTRINSIC RV): design and clinical protocol.
    Olshansky B; Day J; McGuire M; Pratt T
    Pacing Clin Electrophysiol; 2005 Jan; 28(1):62-6. PubMed ID: 15660805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
    Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
    Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy.
    Albert CM; Quigg R; Saba S; Estes NA; Shaechter A; Subacius H; Howard A; Levine J; Kadish A;
    Am Heart J; 2008 Aug; 156(2):367-72. PubMed ID: 18657670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate predicts outcomes in an implantable cardioverter-defibrillator population.
    Ahmadi-Kashani M; Kessler DJ; Day J; Bunch TJ; Stolen KQ; Brown S; Sbaity S; Olshansky B;
    Circulation; 2009 Nov; 120(21):2040-5. PubMed ID: 19901194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction.
    Ermis C; Lurie KG; Zhu AX; Collins J; Vanheel L; Sakaguchi S; Lu F; Pham S; Benditt DG
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):862-6. PubMed ID: 15333075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
    Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of outcomes for patients receiving implantable cardioverter defibrillators for primary vs secondary-prevention.
    Giedrimas A; Giedrimiene D; Guertin D; White CM; Clyne CA; Kluger J
    Conn Med; 2008; 72(6):329-33. PubMed ID: 18610705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study.
    Olshansky B; Day JD; Moore S; Gering L; Rosenbaum M; McGuire M; Brown S; Lerew DR
    Circulation; 2007 Jan; 115(1):9-16. PubMed ID: 17179021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.
    Zareba W; Moss AJ; Jackson Hall W; Wilber DJ; Ruskin JN; McNitt S; Brown M; Wang H;
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1265-70. PubMed ID: 16403053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?
    Daugherty SL; Peterson PN; Wang Y; Curtis JP; Heidenreich PA; Lindenfeld J; Vidaillet HJ; Masoudi FA;
    Am Heart J; 2009 Aug; 158(2):224-9. PubMed ID: 19619698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pacing for soft indications on mortality and heart failure in the dual chamber and VVI implantable defibrillator (DAVID) trial.
    Kutalek SP; Sharma AD; McWilliams MJ; Wilkoff BL; Leonen A; Hallstrom AP; Kudenchuk PJ;
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):828-37. PubMed ID: 18684279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.